Shinkei Therapeutics, Inc.
4Patents
4Active
4Granted
45Portfolio score
Filing activity: Oct 3, 2018 → Oct 26, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11707439B2 | Parenteral treatments involving aminoadamantane derivatives | Human Necessities | 1 | Active |
| US12144899B2 | Tetrabenazine transdermal delivery device | Human Necessities | 0 | Active |
| US11382869B2 | Dextromethorphan transdermal delivery device | Human Necessities | 0 | Active |
| US12396964B2 | Amantadine hydrochloride for the treatment of traumatic brain injury | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.